Point-of-care lung ultrasonography for early identification of mild COVID-19: a prospective cohort of outpatients in a Swiss screening center.
Siméon SchaadThomas BrahierMary-Anne HartleyJean-Baptiste CordonnierLuca BossoTanguy EspejoOlivier PantetOlivier HugliPierre-Nicolas CarronJean-Yves MeuwlyNoémie Boillat-BlancoPublished in: BMJ open (2022)
COVID-19-positive patients are significantly more likely to have lung pathology by LUS. However, LUS has an insufficient sensitivity and is not an appropriate screening tool in outpatients. LUS only adds little value to clinical features alone.